Inhibition of branched-chain alpha-keto acid dehydrogenase kinase augments the sensitivity of ovarian and breast cancer cells to paclitaxel.
Suad Lateef IbrahimMohammed Najim AbedGehad MohamedJoshua C PriceMarwan Ibrahim AbdullahAlan RichardsonPublished in: British journal of cancer (2022)
BCKDK is an attractive target to augment the sensitivity of cancer cells to paclitaxel.
Keyphrases